Lucus Advisors’s CONMED CNMD Stock Holding History

Lucus Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,014	Closed	-$357K	–	201
2017 Q2	$357K	Buy	+7,014	New	+$347K	0.48%	110

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lucus Advisors's CNMD Position: Q3 2017 in Review

Lucus Advisors sold out of CONMED (CNMD) in Q3 2017, closing a stake of 7,014 shares — an estimated $357K sold.

Lucus Advisors first reported a position in CNMD in Q2 2017 and held it in 1 quarter. The position peaked at $357K in Q2 2017. 144 funds tracked by Wall St. Rank hold CNMD as of Q3 2017.

Lucus Advisors reported no remaining CONMED position as of Q3 2017 after selling out during the quarter.
Lucus Advisors sold 7,014 CONMED shares in Q3 2017, an estimated $357K.
Lucus Advisors first reported a position in CONMED in Q2 2017 and held it in 1 quarter.
Lucus Advisors's CONMED position peaked at $357K in Q2 2017.
144 funds tracked by Wall St. Rank held CONMED as of Q3 2017.

Based on Lucus Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.